| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 07/07/2009 | CA2286098C Compositions comprising conjugates of stable, active, human ob protein with antibody fc chain and methods |
| 07/02/2009 | WO2009082449A2 Resuscitation fluid |
| 07/02/2009 | WO2009082359A1 Extended release gliclazide tablet |
| 07/02/2009 | WO2009082354A1 Cross-linked hydrogel containing an active substance |
| 07/02/2009 | WO2009082227A1 A palatable nutritional composition comprising a nucleotide and/or a nucleoside and a taste masking agent |
| 07/02/2009 | WO2009082203A1 Liquid nucleotides/nucleosides-containing product |
| 07/02/2009 | WO2009082014A1 Drug delivery system |
| 07/02/2009 | WO2009081716A1 Spherical grain, method of producing the same and method of producing sustained release preparation |
| 07/02/2009 | WO2009081217A1 Pharmaceutical formulations containing tolperisone |
| 07/02/2009 | WO2009081216A1 Film coated tablets containing drospirenone as active agent and a method for the preparation thereof |
| 07/02/2009 | WO2009081174A2 Anti - retroviral combination |
| 07/02/2009 | WO2009081107A1 P-menthawe-3-carboxylic acid esters to treat airways diseases |
| 07/02/2009 | WO2009081063A1 Device for determining the bioadhesiveness of pasty preparations |
| 07/02/2009 | WO2009080934A2 Allergen desensitization method |
| 07/02/2009 | WO2009080933A1 Method and compositions for cutaneous immunisation |
| 07/02/2009 | WO2009080837A1 Medicament for the treatment of cancer of the pancreas |
| 07/02/2009 | WO2009080762A2 Pharmaceutical composition |
| 07/02/2009 | WO2009080702A1 Microcapsules comprising a fat -soluble active substance |
| 07/02/2009 | WO2009080698A1 Active pharmaceutical ingredient on a solid support, amorphous and with an improved solubility |
| 07/02/2009 | WO2009080541A1 Antibody formulation |
| 07/02/2009 | WO2009080364A1 Raloxifene composition |
| 07/02/2009 | WO2009080275A1 Extruded rod-shaped devices for controlled release of biological substances to humans and animals |
| 07/02/2009 | WO2009080164A1 Solid lipid microcapsules containing growth hormone in the inner solid core |
| 07/02/2009 | WO2009080061A1 Sustained-release pharmaceutical formulation containing an antimuscarinic agent and a wetting agent as well as a process for the preparation thereof |
| 07/02/2009 | WO2009080033A1 Compressed chewing gum comprising metformin |
| 07/02/2009 | WO2009080032A1 Compressed chewing gum comprising a systemically active small peptide |
| 07/02/2009 | WO2009080025A1 Compressed chewing gum comprising metformin |
| 07/02/2009 | WO2009080024A1 Compressed chewing gum comprising an incretin mimetic |
| 07/02/2009 | WO2009080023A1 Compressed chewing gum comprising peptide |
| 07/02/2009 | WO2009080022A1 Compressed chewing gum tablet |
| 07/02/2009 | WO2009080021A1 Compressed chewing gum tablet |
| 07/02/2009 | WO2009080020A1 Chewing gum tablet and method of dosing pharmaceutically active ingredients in such chewing gum tablet |
| 07/02/2009 | WO2009079902A1 The preparation and use of a curcumin-zinc compound and its solid dispersion |
| 07/02/2009 | WO2009079878A1 Injection comprising docetaxel and its preparation |
| 07/02/2009 | WO2009079860A1 Medicament for treating obesity or fatty liver disease |
| 07/02/2009 | WO2009079837A1 A pharmaceutical formulation containing recombinant human serum albumin-interferon alpha fusion protein |
| 07/02/2009 | WO2009079796A1 Recombinant rsv antigens |
| 07/02/2009 | WO2009079688A1 Porous silica shell-mediated assembly of macromolecular capsules |
| 07/02/2009 | WO2009079679A2 Pharmaceutical composition for the parenteral administration of ultrashort-effective beta-adrenoreceptor antagonists |
| 07/02/2009 | WO2009063484A3 Stable pharmaceutical composition of lamotrigine |
| 07/02/2009 | WO2009061607A3 Water-immiscible materials as vehicles for drug delivery |
| 07/02/2009 | WO2009061105A3 Stabilized preparation containing coenzyme q10 and process for preparation thereof |
| 07/02/2009 | WO2009052519A3 Co-polymer stabilizers for hydrofluoroalkane dispersions |
| 07/02/2009 | WO2009047788A3 Topical composition containing the combination of mupirocin and beclomethasone |
| 07/02/2009 | WO2009047785A3 A non-aqueous topical solution of diclofenac and process for preparing the same |
| 07/02/2009 | WO2009047640A3 Method for treating and/or preventing photoreceptor damage in retina |
| 07/02/2009 | WO2009047300A3 Device for administering cells and cell-therapy methods using said device |
| 07/02/2009 | WO2009042809A8 Stable imatinib compositions |
| 07/02/2009 | WO2009035562A3 Drug cores for sustained release of therapeutic agents |
| 07/02/2009 | WO2009007573A3 Method for preparing a granulated form |
| 07/02/2009 | WO2008104590A3 Novel dosage form |
| 07/02/2009 | WO2008066716A9 Film-coated solid dosage form |
| 07/02/2009 | WO2007103286A3 Rate-controlled bioadhesive oral dosage formulations |
| 07/02/2009 | US20090171467 Implantable cartilaginous tissue repair device |
| 07/02/2009 | US20090171406 Electrically conducting scaffolds for cell-based pacing |
| 07/02/2009 | US20090171077 Delivery of nucleic acid-like compounds |
| 07/02/2009 | US20090170811 Composition for treatment of a detached retina and method of prodution thereof |
| 07/02/2009 | US20090170761 Sustained release preparation of pro-insulin c-peptide |
| 07/02/2009 | US20090169641 Compressible particles |
| 07/02/2009 | US20090169640 Compositons for nasal administration of pharmaceuticals |
| 07/02/2009 | US20090169639 Particles for injection and processes for forming the same |
| 07/02/2009 | US20090169638 Inhibitors of ribonucleotide reductase subunit 2 and uses thereof |
| 07/02/2009 | US20090169637 Nanocomposite particles |
| 07/02/2009 | US20090169636 Microparticles containing biodegradable polymer and cationic polysaccharide for use in immunogenic compositions |
| 07/02/2009 | US20090169635 Pharmaceutical compositions and use thereof |
| 07/02/2009 | US20090169634 DNA vaccine comprising IL-6-encoding DNA construct and applications thereof |
| 07/02/2009 | US20090169633 Oral particle including pseudoephedrine hydrochloride and cetirizine dihydrochloride |
| 07/02/2009 | US20090169632 Sustained release composition and manufacturing method thereof |
| 07/02/2009 | US20090169631 Micronized opioid compositions, formulations and dosage forms and methods of making same |
| 07/02/2009 | US20090169630 Methods and Compositions for Controlled and Sustained Production and Delivery of Peroxides and/or Oxygen for Biological and Industrial Applications |
| 07/02/2009 | US20090169629 Micellar compositions with ophthalmic applications |
| 07/02/2009 | US20090169628 Article and method for focused delivery of therapeutic and/or diagnostic materials |
| 07/02/2009 | US20090169627 Particles for injection and processes for forming the same |
| 07/02/2009 | US20090169626 Tamper resistant dosage forms |
| 07/02/2009 | US20090169625 Electrostatically Controlled Hydrogels |
| 07/02/2009 | US20090169624 Observing elution of compound from matrix comprising buffered detergents; assessing and controlling manufacturing process variability of drug eluting implantable devices such as cardiac leads |
| 07/02/2009 | US20090169623 Use of ginsenosides and extracts containing them |
| 07/02/2009 | US20090169622 Delayed-release oral pharmaceutical composition for treatment of colonic disorders |
| 07/02/2009 | US20090169621 Pharmaceutical excipient having improved compressibility |
| 07/02/2009 | US20090169620 Orally disintegrating tablet compositions of temazepam |
| 07/02/2009 | US20090169619 Carbamazepine extended release dosage form |
| 07/02/2009 | US20090169618 Zolpidem pharmaceutical compositions |
| 07/02/2009 | US20090169617 Controlled Release Formulations Comprising Uncoated Discrete Unit(s) and an Extended Release Matrix |
| 07/02/2009 | US20090169616 Formulation and method for the release of paroxetine in the large intestine |
| 07/02/2009 | US20090169615 Collagen Formulations for Improved Skin Care |
| 07/02/2009 | US20090169614 Methods of suppressing microglial activation and systemic inflammatory responses |
| 07/02/2009 | US20090169613 Targeting of tumor stem cells through selective silencing of boris expression |
| 07/02/2009 | US20090169612 Systemic Immune Activation Method Using Nucleic Acid-Lipid Complexes |
| 07/02/2009 | US20090169611 Gel-Formulations of Hydrophobic Photosensitizers for Mucosal Applications |
| 07/02/2009 | US20090169610 Liposome Preparation |
| 07/02/2009 | US20090169609 Pqs and its conjugates as adjuvants and their uses in pharmaceutical compositions |
| 07/02/2009 | US20090169608 Topically applicable composition for use as a skin bleaching agent |
| 07/02/2009 | US20090169607 Pharmaceutical Compositions Comprising Cyclosporin |
| 07/02/2009 | US20090169606 Low Flexural Strength Transdermal Tobacco Alkaloid Patch |
| 07/02/2009 | US20090169604 Adhesive Pharmaceutical Preparation Containing Bisoprolol |
| 07/02/2009 | US20090169603 Adhesive Pharmaceutical Preparation |
| 07/02/2009 | US20090169602 Allergy Treatment by Epicutaneous Allergen Administration |
| 07/02/2009 | US20090169601 Transdermal Therapeutic System for Administering Lipophilic and/or Sparingly Skin- Permeable Active Substances |
| 07/02/2009 | US20090169600 Hydrogen Peroxide Delivery System |
| 07/02/2009 | US20090169599 Scientifically modulated and reprogrammed treatment (smart) fas/fasl virus technology intended to neutralize t-helper cells infected with the human immunodeficiency virus |